DURHAM, N.C., Aug. 08, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or “the Company”), a global leader in innovations for active healing, today reported financial results for the three and six months ended July 1, 2023. Q2 Financial Summary: Net Sales of $137.1 million, down $3.3 million, or…Read More
Bioventus Inc Bioventus Reports Second Quarter Financial Results Introduces Full Year 2023 Financial Guidance
